Helix VaxApp gets approval from NHSE to boost vaccine management   

  • 28 March 2023
Helix VaxApp gets approval from NHSE to boost vaccine management    

MedicalDirector UK’s Helix VaxApp has received approval from NHS England to be used across the health service’s Covid and flu vaccination programmes. 

This milestone marks a significant achievement in the ongoing efforts to combat Covid-19 virus variants and support public health efforts across the UK.  

The Helix VaxApp is a cutting-edge vaccination management and tracking system designed to streamline the vaccination process and improve patient outcomes.

With its intuitive user interface and robust data management capabilities, the Helix VaxApp enables healthcare providers to efficiently manage vaccine supplies, track patient vaccination status, and monitor adverse reactions.  

It has been developed in line with the UK government’s £484 million investment programme to upgrade clinical health record technology and is available as part of NHS funding. 

“Helix VaxApp is a simple, secure, cloud-based solution that enables management of Covid-19 and flu vaccinations from anywhere, which allows providers to be fully mobile and go to their patients’ locations – whether that be a care home, school or even a patient’s home,” Jack Gibson, product lead for MedicalDirector UK, said.

“It can be accessed through a web browser on a tablet or laptop, with no software installation necessary.

“The system is fully mobile which means it can be used for vaccinations with only a Wi-Fi connection or phone hotspot, connecting seamlessly to core NHS Spine services like Personal Demographics Service (PDS), as well as the National Immunisation Management System.”   

Following a successful pilot programme, the Helix VaxApp has been approved for full rollout across the NHS. This means that healthcare providers across the country will now have funded access to this innovative vaccination management system, allowing them to provide faster, more efficient care to patients.   

Gibson added: “We are thrilled to receive full rollout approval from NHS England. The Helix VaxApp is a game-changer in the fight against Covid-19, and we believe it will be an invaluable tool for healthcare providers across the country as they work to vaccinate as many people as possible.

“We look forward to building our partnership with NHS England to support public health efforts and improve patient outcomes.”  

MedicalDirector UK is part of Telstra Health UK, a healthcare data and solutions provider with metrics that have been adopted as global standards in healthcare.

Telstra Health UK is part of Telstra Health, which provides digital solutions and services to healthcare providers and governments across the care continuum in Australia and internationally. 

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Facial recognition tech for pain management trialled in Bedfordshire

Facial recognition tech for pain management trialled in Bedfordshire

Facial recognition technology for pain management is being trialled at residential and nursing homes in Bedfordshire, Luton and Milton Keynes.
UK government to create surveillance system for future pandemics

UK government to create surveillance system for future pandemics

The UK government has announced plans to create a real-time surveillance system to monitor the threat of future pandemics and prevent disease.
NHS pilots iPhone device for throat cancer detection

NHS pilots iPhone device for throat cancer detection

The NHS is piloting an iPhone device and app that helps detect throat cancer earlier and give patients the all-clear for the disease faster.